AEGiS-Chicago Tribune: AIDS Lab Offers Hope of Vaccine Chicago TribuneImportant note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
Click here to return to Chicago Tribune main menu
DonateNow


AIDS Lab Offers Hope of Vaccine

Chicago Tribune (CT) - Friday, August 30, 1985, Page: 5
Jon Van, Science writer


Texas researchers have synthesized a portion of the virus thought to cause AIDS, a step that could lead to a vaccine against the deadly disease.

Dr. Gordon Dreesman of the Southwest Foundation for Biomedical Research, in San Antonio, said Thursday that his lab had synthesized a sequence of 18 amino acids that match a portion of the virus, known as HTLV-III.

Scientists consider this a significant achievement and an important first step toward developing a vaccine and better tests to diagnose AIDS, or acquired immune deficiency syndrome.

Dreesman and his colleagues have begun experiments to determine if the synthetic protein they have made could protect people against AIDS. The lab has injected the protein material, called a peptide, into laboratory mice and rabbits to see if it elicits antibodies against the virus.

If the animals produce antibodies, and if those antibodies neutralize the HTLV-III virus, Dreesman plans to inject his synthetic peptides into chimpanzees and then challenge them with injections of the virus. This could occur as early as November, he said.

"After the challenge, we would have to monitor the animals for a long time, perhaps 12 months, to see if they develop an infection," Dreesman said. "This disease has such a long incubation period, you have to wait a long time for anything to happen."

If the chimpanzees were protected against AIDS infection, Dreesman said, the U.S. Food and Drug Administration could decide whether vaccine tests should be performed on humans at high risk of developing AIDS. That decision could be made in 1987, if all tests on animals were successful.

Dreesman, whose work is supported by a grant from the National Institutes of Health, said the segment of HTLV-III virus chosen for synthesis apparently remains stable in the virus.

Dreesman's peptide synthesis was described as important research by Dr. George Nemo of the National Institutes of Health. It was done in collaboration with Dr. Myron Essex of Harvard University.

In another development Thursday, the federal Centers for Disease Control in Atlanta urged that children with AIDS be allowed to attend regular school classes in most cases.

"Casual person-to-person contact, as would occur among schoolchildren, appears to pose no risk," the agency said.

The disease, which cripples a person's ability to fight infections, is transmitted through blood, semen or other bodily fluids and not through casual contact, said Dr. Martha Rogers of the agency.

At least 183 people younger than 18 have been diagnosed with AIDS, Rogers said. Despite the lack of a good reason for keeping them out of school, none has been allowed to attend, as far as researchers know, she said.

A more restricted environment is recommended for infected children if they are younger than school age, are handicapped and cannot control their body secretions or if they might bite other children.


Keywords: DISEASE; MEDICINE; RESEARCH; FORECAST

KWDdisease;medicine;research;forecast
850830
CT850805


Copyright © 1985 - Chicago Tribune. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Chicago Tribune, Permissions Desk, 435 North Michigan Avenue, Chicago, IL 60611  http://www.chicagotribune.com

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, Pacific Life Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .